Effect of a poly herbal mouthwash in prevention of mucositis
Phase 3
Recruiting
- Conditions
- oral mucositis.Oral mucositis (ulcerative)K12.3
- Registration Number
- IRCT20190123042475N2
- Lead Sponsor
- Bojnourd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
All patients over the age of 18 undergoing radiotherapy
Exclusion Criteria
co-existing systemic diseases
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical manifestations of mucositis. Timepoint: In the beginning of the study (before the onset of intervention), 1,2,3,4,5,6,7,8 weeks after commencing oral intake of poly herbal mouthwash. Method of measurement: Clinical Examination.;Severity of mucositis based on the WHO benchmark. Timepoint: In the beginning of the study (before the onset of intervention), 1,2,3,4,5,6,7,8 weeks after commencing oral intake of poly herbal mouthwash. Method of measurement: World Health Organization classification system.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie poly herbal mouthwash efficacy in preventing mucositis?
How does poly herbal mouthwash compare to standard-of-care agents like chlorhexidine for mucositis prevention?
Are there specific biomarkers that predict response to poly herbal mouthwash in head and neck cancer patients?
What adverse events are associated with poly herbal mouthwash use during radiotherapy and how are they managed?
What are the key components of the poly herbal mouthwash and how do they synergize with other mucositis treatments?